Company intelligence / Profile preview

Bayesian Health

New York, New York, United Statesbayesianhealth.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bayesian Health’s adaptive AI platform has demonstrated significant improvements in patient outcomes. For example, its sepsis module reduced mortality by 18.2%, improved responsiveness by nearly two hours, and achieved an 89% clinician adoption rate in prospective studies and real-world deployments. The company’s tools are recognized for high sensitivity, precision, and strong physician engagement.

Therapeutic areas: OtherDermatologyInfectious Diseases
Modalities: Device (clinical decision support software/AI platform)
Industry: Digital Health Medical Devices

Partnerships

Academic health systems/hospitals including Johns Hopkins Medicine; specific names not fully disclosed but referenced as "preeminent Academic Health Systems" with deep integration partnerships.

Beyond the preview

Go deeper on Bayesian Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bayesian Health.

Explore the full profile